Eloxx Pharmaceuticals (ELOX) Liabilities and Shareholders Equity (2011 - 2026)
Eloxx Pharmaceuticals (ELOX) reported Liabilities and Shareholders Equity of $63.39 million for Q2 2026, up 645.5% from the prior quarter.
Powered by 
Analysis
Eloxx Pharmaceuticals (ELOX) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
At the end of FY2025, Eloxx Pharmaceuticals posted Liabilities and Shareholders Equity of $5.27 million, up 77.1% from FY2024.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of -27.6% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $2.98 million in FY2024 (+73.8%), $1.71 million in FY2023 (-91.9%), $21.12 million in FY2022 (-53.2%) and $45.14 million in FY2021 (+70.5%).
- The Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity since Q3 2019.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q1 2022 (growth of 114.2%); the low point was Q4 2023 (a decline of 91.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,149.64 Bn | 1,118.23 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 626.55 Bn | 545.08 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 498.79 Bn | 471.91 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 371.66 Bn | 326.04 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 299.96 Bn | 263.95 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 263.22 Bn | 236.91 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.03 Bn | 192.43 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.20 Bn | 165.40 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.83 Bn | 117.47 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Eloxx Pharmaceuticals | 89.62 Mn | 15.94 Mn | - | 63.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.39 Mn |
| Mar 31, 2026 | 8.50 Mn |
| Dec 31, 2025 | 5.27 Mn |
| Dec 31, 2024 | 2.98 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 6.04 Mn |
| Jun 30, 2023 | 5.99 Mn |
| Mar 31, 2023 | 7.20 Mn |
| Dec 31, 2022 | 21.12 Mn |
| Sep 30, 2022 | 26.88 Mn |
| Jun 30, 2022 | 32.94 Mn |
| Mar 31, 2022 | 43.62 Mn |
| Dec 31, 2021 | 45.14 Mn |
| Sep 30, 2021 | 55.38 Mn |
| Jun 30, 2021 | 60.61 Mn |
| Mar 31, 2021 | 20.37 Mn |
| Dec 31, 2020 | 26.48 Mn |
| Sep 30, 2020 | 32.94 Mn |
| Jun 30, 2020 | 39.92 Mn |
| Mar 31, 2020 | 47.04 Mn |
API Access
Eloxx Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ELOX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ELOX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ELOX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();